A
Andrew W. Roddam
Researcher at University of Oxford
Publications - 88
Citations - 11753
Andrew W. Roddam is an academic researcher from University of Oxford. The author has contributed to research in topics: European Prospective Investigation into Cancer and Nutrition & Risk factor. The author has an hindex of 56, co-authored 87 publications receiving 11042 citations. Previous affiliations of Andrew W. Roddam include Cancer Epidemiology Unit & Amgen.
Papers
More filters
Journal ArticleDOI
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
Timothy J. Key,Paul N. Appleby,Gillian K Reeves,Andrew W. Roddam,Joanne F. Dorgan,Christopher Longcope,Frank Z. Stanczyk,Hugh E. Stephenson,Roni T. Falk,Rosetta Miller,Arthur Schatzkin,D. S. Allen,Ian S. Fentiman,D. Y. Wang,Mitch Dowsett,H V Thomas,Susan E. Hankinson,Paolo Toniolo,Arslan Akhmedkhanov,Karen L. Koenig,Roy E. Shore,Anne Zeleniuch-Jacquotte,Franco Berrino,Paola Muti,Andrea Micheli,Vittorio Krogh,Sabina Sieri,Valeria Pala,Elisabetta Venturelli,Giorgio Secreto,Elizabeth Barrett-Connor,Gail A. Laughlin,Michinori Kabuto,Suminori Akiba,Richard G. Stevens,Kazuo Neriishi,Charles E. Land,J. A. Cauley,Lewis H. Kuller,Steve Cummings,Kathy J. Helzlsouer,Anthony J. Alberg,Trudy L. Bush,George W. Comstock,Gary B. Gordon,Miller +45 more
TL;DR: In this paper, the authors examined whether the relationship of body mass index (BMI) with serum sex hormone concentrations could be explained by the relationship between BMI and estradiol levels.
Journal ArticleDOI
Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies
TL;DR: Serious associations were found between the risk of prostate cancer and serum concentrations of testosterone, calculated free testosterone, dihydrotestosterone, dehydroepiandrosterone sulfate, androstenedione, androstanediol glucuronide, estradiol, or calculated freeEstradiol.
Journal ArticleDOI
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.
TL;DR: Circulating IGF1 is positively associated with breast-cancer risk, and the association is not substantially modified by IGFBP3, and does not differ markedly by menopausal status, but seems to be confined to oestrogen-receptor-positive tumours.
Journal ArticleDOI
Body Size and Risk of Colon and Rectal Cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC)
Tobias Pischon,Petra H. Lahmann,Heiner Boeing,Christine M. Friedenreich,Teresa Norat,Anne Tjønneland,Jytte Halkjær,Kim Overvad,Françoise Clavel-Chapelon,Marie-Christine Boutron-Ruault,Gregory Guernec,Manuela M. Bergmann,Jakob Linseisen,Nikolaus Becker,Antonia Trichopoulou,Dimitrios Trichopoulos,Sabina Sieri,Domenico Palli,Rosario Tumino,Paolo Vineis,Paolo Vineis,Salvatore Panico,Petra H.M. Peeters,H. Bas Bueno-de-Mesquita,Hendriek C. Boshuizen,Bethany Van Guelpen,Richard Palmqvist,Göran Berglund,Carlos A. González,Miren Dorronsoro,Aurelio Barricarte,Carmen Navarro,Carmen Martinez,J. Ramón Quirós,Andrew W. Roddam,Naomi E. Allen,Sheila Bingham,Kay-Tee Khaw,Pietro Ferrari,Rudolf Kaaks,Nadia Slimani,Elio Riboli +41 more
TL;DR: In this paper, the authors used multivariable adjusted Cox proportional hazards models to examine the association between anthropometric measures and risks of colon and rectal cancer among 368 277 men and women who were free of cancer at baseline from nine countries of the European Prospective Investigation Into Cancer and Nutrition.